Provided by Tiger Trade Technology Pte. Ltd.

Iambic Therapeutics

23.81
+4.9025.91%
Post-market: 24.000.1900+0.80%19:59 EDT
Volume:2.96M
Turnover:67.77M
Market Cap:1.13B
PE:-11.98
High:25.00
Open:19.31
Low:19.31
Close:18.91
52wk High:25.00
52wk Low:16.15
Shares:47.40M
Float Shares:9.40M
Volume Ratio:1.47
T/O Rate:31.54%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.9880
EPS(LYR):-3.5749
ROE:-54.21%
ROA:-29.35%
PB:-4.85
PE(LYR):-6.66

Loading ...

From Algorithms To Oncology: Why IAM Jumped On Day One

Bellwether Stocks Movement
·
Yesterday

Iambic Therapeutics Completes IPO and Updates Governance

TIPRANKS
·
9 hours ago

Top Midday Gainers

MT Newswires Live
·
12 hours ago

Cathie Wood's ARK Reveals Latest Portfolio Moves: Adds More CoreWeave, Buys Nearly $19 Million in Iambic Shares, Trims Amazon and Palantir

Deep News
·
Yesterday

Cathie Wood’s ARK Investment buys 1.18M shares of Iambic Therapeutics today

TIPRANKS
·
Yesterday

Nvidia-Backed Iambic Therapeutics Jumps in Debut After $150 Million IPO

Reuters
·
Yesterday

AI Cancer-Fighting Iambic Therapeutics Stock (IAM) Rockets 13% After $150M IPO

TIPRANKS
·
Yesterday

Iambic Therapeutics Shares Rise in Nasdaq Debut

MT Newswires Live
·
Yesterday

NASDAQ Trade Halt Volatility Trading Pause at 12:12 Pm

Reuters
·
Yesterday

Iambic Therapeutics Prices $150 Million Initial Public Offering

MT Newswires Live
·
Oct 15

NASDAQ Trade Halt Reason not Available at 04:00 Am

Reuters
·
Oct 15

Nvidia-backed AI cancer drug developer Iambic (IAM.US) debuts on Nasdaq: priced at midpoint of range, raising $150 million

Stock News
·
Oct 15

Iambic Therapeutics 9.375M share IPO priced at $16.00

TIPRANKS
·
Oct 15

Iambic Therapeutics - Prices IPO of 9,375,000 Shares at $16 Per Share

THOMSON REUTERS
·
Oct 15

Iambic Announces Pricing of Initial Public Offering

THOMSON REUTERS
·
Oct 15

BIO-key Names Cybersecurity Veteran Stephen Morrow President of PortalGuard to Drive Accelerated Adoption of its Innovative IAM Solution

GlobeNewswire
·
Oct 13

BIO-key Adds New Middle East Government Security Agency Customer, Expanding Regional Footprint

GlobeNewswire
·
Oct 13

Is Okta (OKTA) Fully Priced On Its Yubico Partnership And AI Security Push?

Simply Wall St.
·
Oct 11

Iambic Therapeutics Sets IPO Price Range at $15-$17 per Share to Raise $150 Million

Stock News
·
Oct 09

Nvidia-Backed Iambic Therapeutics Launches IPO as Biotechs Buck Market Gloom

Reuters
·
Oct 09